You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
向日葵(300111.SZ):子公司貝得藥業變更經營範圍 涉第一類醫療器械銷售等
格隆匯 05-27 20:04

格隆匯5月27日丨向日葵(300111.SZ)公佈,公司的控股子公司浙江貝得藥業有限公司(“貝得藥業”)因業務發展需要,對其經營範圍進行了變更。近日,貝得藥業已完成工商變更登記手續並取得新的《營業執照》,具體變更情況如下:

變更前經營範圍:生產:凍乾粉針劑、片劑(含頭孢菌素類)、膠囊劑(含頭孢菌素類)、原料藥(拉西地平、泮托拉唑鈉、阿奇黴素、克拉黴素、埃索美拉唑鈉)(上述經營範圍憑有效《藥品生產許可證》經營)、副產品(年回收:丙酮1500噸、二氯甲烷34000噸、甲醇2000噸、乙醇4000噸、甲基叔丁基醚3800噸、六甲基二硅醚100噸(上述經營範圍憑有效《安全生產許可證》經營))、二甲基亞碸、溴化鉀、硫氰酸鈉、對甲苯硫酸鈉、亞硫酸鈉和硫酸鈉混合物;銷售自產產品;醫藥化工技術開發、技術推廣、技術轉讓、技術諮詢、技術服務;貨物進出口。(依法須經批准的項目,經相關部門批准後方可開展經營活動)

變更後經營範圍:一般項目:藥品生產、危險化學品生產(以上憑有效許可證經營);生產:二甲基亞碸、溴化鉀、硫氰酸鈉、對甲苯硫酸鈉、亞硫酸鈉和硫酸鈉混合物(除危險化學品及易製毒化學品);銷售自產產品;醫藥化工技術開發、技術推廣、技術轉讓、技術諮詢、技術服務;包裝服務;第一類醫療器械銷售;第二類醫療器械銷售;(除依法須經批准的項目外,憑營業執照依法自主開展經營活動)。許可項目:貨物進出口(依法須經批准的項目,經相關部門批准後方可開展經營活動,具體經營項目以審批結果為準)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account